216 related articles for article (PubMed ID: 26235268)
1. [Recombinant tissue plasminogen activator for the management of intracardiac thrombi in newborns].
Álvarez Z P; Verdugo L P; Carvajal K L; Múhlhausen M G; Ríos A P; Rodríguez V D
Rev Chil Pediatr; 2015; 86(3):194-9. PubMed ID: 26235268
[TBL] [Abstract][Full Text] [Related]
2. Recombinant Tissue Plasminogen Activator in the Treatment of Neonates with Intracardiac and Great Vessels Thrombosis.
El-Segaier M; Khan MA; Khan ZU; Momenah T; Galal MO
Pediatr Cardiol; 2015 Dec; 36(8):1582-7. PubMed ID: 25991571
[TBL] [Abstract][Full Text] [Related]
3. The use of recombinant tissue-type plasminogen activator in a newborn with an intracardiac thrombus developed during extracorporeal membrane oxygenation.
Garcia A; Gander JW; Gross ER; Reichstein A; Sheth SS; Stolar CJ; Middlesworth W
J Pediatr Surg; 2011 Oct; 46(10):2021-4. PubMed ID: 22008344
[TBL] [Abstract][Full Text] [Related]
4. Successful thrombolysis of acute left atrial thrombi in two pediatric patients following interventional cardiac catheterization.
Herron SB; Lax D; Zamora R
J Invasive Cardiol; 2004 Jan; 16(1):35-9. PubMed ID: 14699222
[TBL] [Abstract][Full Text] [Related]
5. Prior Asymptomatic Parenchymal Hemorrhage Does Not Increase the Risk for Intracranial Hemorrhage after Intravenous Thrombolysis.
AbdelRazek MA; Mowla A; Hojnacki D; Zimmer W; Elsadek R; Abdelhamid N; Elsadek L; Farooq S; Kamal H; Crumlish A; Shirani P; Ching M; Sawyer R
Cerebrovasc Dis; 2015; 40(5-6):201-4. PubMed ID: 26402147
[TBL] [Abstract][Full Text] [Related]
6. Does antithrombotic therapy influence residual thrombus after thrombolysis of platelet-rich thrombus? Effects of recombinant hirudin, heparin, or aspirin.
Mruk JS; Zoldhelyi P; Webster MW; Heras M; Grill DE; Holmes DR; Fuster V; Chesebro JH
Circulation; 1996 Feb; 93(4):792-9. PubMed ID: 8641009
[TBL] [Abstract][Full Text] [Related]
7. Management of preterm infants with intracardiac thrombi: use of thrombolytic agents.
Rimensberger PC; Humbert JR; Beghetti M
Paediatr Drugs; 2001; 3(12):883-98. PubMed ID: 11772150
[TBL] [Abstract][Full Text] [Related]
8. Catheter-Directed Low-Dose Tissue Plasminogen Activator for Treatment of Right Atrial Thrombus Caused by a Central Venous Catheter.
Orgeron GM; Pollard JL; Pourmalek P; Sloane PJ
Pharmacotherapy; 2015 Oct; 35(10):e153-8. PubMed ID: 26497485
[TBL] [Abstract][Full Text] [Related]
9. Low dose tissue plasminogen activator treatment for vascular thrombosis following cardiac catheterization in children: a single center experience.
Bratincsák A; Moore JW; El-Said HG
Catheter Cardiovasc Interv; 2013 Nov; 82(5):782-5. PubMed ID: 22718305
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment of a catheter-related right atrial thrombosis with recombinant tissue plasminogen activator and heparin.
Cesaro S; Paris M; Corrò R; Svaluto G; Zanon GF; Gamba P; Milanesi O; Messina C; Zanesco L
Support Care Cancer; 2002 Apr; 10(3):253-5. PubMed ID: 11904791
[TBL] [Abstract][Full Text] [Related]
11. Left ventricular apical thrombus after systemic thrombolysis with recombinant tissue plasminogen activator in a patient with acute ischemic stroke.
Doepp F; Sanad W; Schreiber SJ; Baumann G; Borges AC
Cardiovasc Ultrasound; 2005 May; 3():14. PubMed ID: 15918893
[TBL] [Abstract][Full Text] [Related]
12. Use of tissue plasminogen activator to treat intracardiac thrombosis in extremely low-birth-weight infants.
Bose J; Clarke P
Pediatr Crit Care Med; 2011 Nov; 12(6):e407-9. PubMed ID: 21131893
[TBL] [Abstract][Full Text] [Related]
13. Combined rTPA and aspirin therapy for intracardiac thrombosis in neonates.
Tardin FA; Avanza AC; Andião MR; Rabello SM; Cristello Ede M; Baltan EC; Pegurin EB; Oliveira NS
Arq Bras Cardiol; 2007 May; 88(5):e121-3. PubMed ID: 17589617
[TBL] [Abstract][Full Text] [Related]
14. Combined thrombolytic therapy for atrial thrombus in a preterm infant.
Mondì V; Di Paolo A; Fabiano A; Cicchese M; De Merulis G; Giannini C; Del Principe D
Minerva Pediatr; 2011 Apr; 63(2):115-8. PubMed ID: 21487375
[TBL] [Abstract][Full Text] [Related]
15. Management of a large organized intraatrial catheter-tip thrombus in a child with acquired immunodeficiency syndrome using escalating tissue plasminogen activator infusions.
Mathur M; Desai N; Sharma J; Rao SP; Goldman GM
Pediatr Crit Care Med; 2005 Jan; 6(1):79-82. PubMed ID: 15636665
[TBL] [Abstract][Full Text] [Related]
16. Acute iliofemoral venous thrombosis in patients with atresia of the inferior vena cava can be treated successfully with catheter-directed thrombolysis.
Broholm R; Jørgensen M; Just S; Jensen LP; Bækgaard N
J Vasc Interv Radiol; 2011 Jun; 22(6):801-5. PubMed ID: 21459610
[TBL] [Abstract][Full Text] [Related]
17. [Successful lysis of a mobile left ventricular thrombus by slow infusion of low-dose tissue plasminogen activator].
Güneş Y; Ceylan Y; Tuncer M
Turk Kardiyol Dern Ars; 2010 Oct; 38(7):489-91. PubMed ID: 21206203
[TBL] [Abstract][Full Text] [Related]
18. Life threatening cavopulmonary thrombus: resolution within 24 h with tissue plasminogen activator.
Malagon I; Evens FC; Freund MW
Paediatr Anaesth; 2008 Apr; 18(4):343-4. PubMed ID: 18315651
[No Abstract] [Full Text] [Related]
19. Safety and outcomes of thrombolysis with tissue plasminogen activator for treatment of intravascular thrombosis in children.
Gupta AA; Leaker M; Andrew M; Massicotte P; Liu L; Benson LN; McCrindle BW
J Pediatr; 2001 Nov; 139(5):682-8. PubMed ID: 11713447
[TBL] [Abstract][Full Text] [Related]
20. Clinical experience with recombinant tissue plasminogen activator in the management of intracardiac and arterial thrombosis in children.
Olgun H; Buyukavci M; Ceviz N; Sahin IO; Yildirim ZK; Colak A; Tekgunduz KS; Caner I
Blood Coagul Fibrinolysis; 2014 Oct; 25(7):726-30. PubMed ID: 24806322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
